Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cannabis Global's enterprise value is $0.66 Mil.
Cannabis Global's EBITDA for the trailing twelve months (TTM) ended in May. 2022 was $2.59 Mil. Therefore, Cannabis Global's EV-to-EBITDA for today is 0.25.
The historical rank and industry rank for Cannabis Global's EV-to-EBITDA or its related term are showing as below:
CBGL'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.25
Current: 0.25
During the past 13 years, the highest EV-to-EBITDA of Cannabis Global was 0.25. The lowest was 0.00. And the median was 0.00.
CBGL's EV-to-EBITDA is not ranked
in the Drug Manufacturers industry.
Industry Median: 12.98
vs CBGL: 0.25
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Cannabis Global (OTCPK:CBGL) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cannabis Global's PE Ratio (TTM) for today is calculated as:
Cannabis Global's share price for today is $0.0001.
Cannabis Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.022.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Cannabis Global's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabis Global EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cannabis Global's EV-to-EBITDA falls into.
Cannabis Global's current Enterprise Value is $0.66 Mil.
Cannabis Global's EBITDA for the trailing twelve months (TTM) ended in May. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.59 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabis Global (CBGL) has a EV-to-EBITDA of 0.25 as of Jul. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Cannabis Global.
Is Cannabis Global's EV-to-EBITDA too high?
Cannabis Global's current EV-to-EBITDA is 0.25. The Drug Manufacturers industry median EV-to-EBITDA is 12.98. Cannabis Global's value of 0.25 is 98.1% below this industry median.
How does Cannabis Global's EV-to-EBITDA compare to MILC and BBBT?
Cannabis Global's EV-to-EBITDA of 0.25 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBITDA is 12.98. Cannabis Global's value of 0.25 is 98.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 12.98, based on 739 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabis Global's current EV-to-EBITDA of 0.25 is 98.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Cannabis Global. For the Drug Manufacturers industry, the median EV-to-EBITDA is 12.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Global's current EV-to-EBITDA is 0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Global stock overvalued right now?
Cannabis Global (CBGL) has a current EV-to-EBITDA of 0.25. The current EV-to-EBITDA is 0.25 and 98.1% below the Drug Manufacturers industry median of 12.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Cannabis Global (CBGL), the current EV-to-EBITDA is 0.25 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabis Global Inc manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBGL has been successfully added to your 
